98%
921
2 minutes
20
Background: In Japan, as several important vaccines are still categorized as voluntary vaccines that require out-of-pocket payment, the vaccination coverage of voluntary vaccines is lower than that of routine vaccines. Thus, higher voluntary vaccination rates are desired. Herein, we used nationwide birth cohort data to create a voluntary vaccine risk score to identify high-risk individuals who were not vaccinated with voluntary vaccines.
Methods: The data from 74,733; 73,571; and 74,360 infants were analyzed for rotavirus, mumps virus, and influenza virus vaccinations, respectively. The risk score for non-vaccination of voluntary vaccines was created from the regression coefficients of the logistic regression models.
Results: The items included for the score resulted from the analysis were the mother's drug allergy history, mother's depression history, mother's educational background, father's educational background, household income, maternal smoking during pregnancy, paternal smoking during pregnancy, fertility treatment, number of siblings, maternal drinking at 1 month of age, maternal age, and maternal nationality. The mother's drug allergy history, mother's depression history, fertility treatment, maternal drinking at 1 month of age, and maternal nationality were factors not previously reported and associated with taking voluntary vaccine. The receiver operating characteristic curve of the risk score for non-vaccination of voluntary vaccines suggested that a score ≥16 predicted non-vaccinated infants for rotavirus, mumps virus, and influenza virus vaccines with 78.6%, 75.0%, and 74.5% sensitivity and 44.2%, 43.2%, and 37.1% specificity, respectively.
Conclusions: We developed a risk score for non-vaccination of voluntary vaccines consisting of 10 domains with high sensitivity but low specificity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/ped.15888 | DOI Listing |
Int J Infect Dis
September 2025
PandemiX Center of Excellence, Department of Science and Environment, Roskilde University, Denmark.
When a new pandemic virus emerges in a naive population the only control options are Non-Pharmaceutical Interventions, NPI's, until vaccines or effective treatments become available. Here we report on the Danish suppression strategy and use of a combination of NPI's with a notable absence of extremely strict measures (such as stay-at-home orders). Only 7% were infected (serological evidence) in the first year of the pandemic, compared to ∼50% in Lombardy in the first wave alone.
View Article and Find Full Text PDFBMC Public Health
September 2025
Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda.
Background: Cholera is endemic in Uganda with periodic outbreaks occurring annually. On July 24, 2023, Uganda's Ministry of Health confirmed a cholera outbreak in Sigulu Island, Namayingo District. We investigated to determine its magnitude, identify possible exposures, and recommend evidence-based control interventions.
View Article and Find Full Text PDFVaccines (Basel)
August 2025
Clinical Department of Paediatrics and Infectious Diseases, Faculty of Medicine, Wroclaw Medical University, Chalubinskiego 2-2A Str., 50-368 Wroclaw, Poland.
Booster vaccination coverage in the adult population in Poland remains insufficient. The objective of this study was to utilize the opportunity of a visit to the Regional Blood Transfusion Center in Wroclaw-associated with blood donation-as a means to remind individuals about the need for tetanus booster vaccination and to assess tetanus immunity in healthy adults (30-40 years after their last mandatory dose) who had not received booster immunizations. : A total of 97 blood donors aged 50 to 64 years (median age: 54 years) were enrolled, of whom 78% were male.
View Article and Find Full Text PDFVaccine
August 2025
College of Pharmacy, Kangwon National University, Chuncheon, Republic of Korea. Electronic address:
Background: Herpes zoster (HZ) vaccination is not publicly funded in Korea. This study aimed to assess the cost-effectiveness of introducing recombinant zoster vaccine (RZV) and zoster vaccine live (ZVL) into Korea's national immunization program (NIP).
Methods: A decision tree Markov model was used to estimate expected costs and quality-adjusted life years (QALYs) by comparing the lifetime cost-effectiveness of NIP vaccination strategies with RZV and ZVL to that of voluntary ZVL vaccination.
Cureus
July 2025
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, USA.
Introduction: While COVID-19 created unique learning experiences within medical education, the pandemic also changed views on global health (GH). There is an important gap in our knowledge regarding the ways in which the unique learning experiences of the COVID-19 pandemic affected medical residents' approach to GH. Our objective is to understand the impact of the COVID-19 pandemic on pediatric graduate education, with special attention given to resident perspectives on GH education.
View Article and Find Full Text PDF